What Does 'Hyperplasia' Mean?

Hyperplasia means there are more cells than usual in a tissue or organ. In most cases, the extra cells still look normal. Hyperplasia is not cancer. It is often a harmless response to a signal. A hormone telling cells to divide is a common trigger.

Some kinds of hyperplasia get watched more closely. Atypical hyperplasia describes extra cells that also look somewhat abnormal. It is not just more cells. It is more cells that also look unusual. That difference changes how doctors respond.

In breast tissue, hyperplasia is a common biopsy finding. Usual ductal hyperplasia describes extra cells that still look close to normal. It raises future breast cancer risk only a little. Studies put that risk at roughly one and a half to two times higher than average. It needs no treatment on its own.

Atypical ductal hyperplasia and atypical lobular hyperplasia are different. These describe extra cells that also look abnormal. They raise future breast cancer risk more. Studies put that risk at roughly four to five times higher than average. If found on a needle biopsy, doctors usually remove more tissue. This checks for something more serious hiding nearby, such as ductal carcinoma in situ. Monitoring after that often means more frequent breast exams and imaging. Sometimes it includes a talk about risk-lowering medicine.

In the lining of the uterus, hyperplasia is graded differently. The category that matters most is atypical endometrial hyperplasia. It is also called endometrial intraepithelial neoplasia, or EIN. This is a direct precancerous change. It is not simply more normal-looking cells.

Left untreated, this finding tends to progress. Research shows it turns into cancer in roughly 8% of cases each year. That risk builds over time.

Cancer is also often already present when this is found. Doctors learn this from surgery. Among women who have a hysterectomy for this finding, 30% to 50% turn out to already have cancer. This cancer is hiding in the removed tissue. It is found only once the whole uterus is examined.

Because of this risk, hysterectomy is the standard treatment. It removes the uterus and settles the question directly. Some women want to keep their fertility. Others cannot have surgery. For them, there is another option. Progestin therapy is a hormone treatment. It is sometimes given through an intrauterine device. It needs repeat testing every few months. This confirms it is working.

These two words are easy to mix up. Hyperplasia is mainly about cell number. Those cells often still look normal. Dysplasia is about cells that look abnormal. This is true no matter how many there are. Of the two, dysplasia is usually the more concerning finding. But atypical hyperplasia, in the breast and uterus, is treated almost as seriously.

Ordinary hyperplasia is not urgent. Atypical hyperplasia is different, especially in the uterus. It deserves prompt follow-up, usually within weeks. Cancer can already exist alongside it in a real share of cases.

• Is this ordinary hyperplasia or atypical hyperplasia?
• Where was it found, and how does that affect my future cancer risk?
• Is more tissue removal recommended, and why?
• If treatment is medical rather than surgical, how often will I need repeat testing?

Hyperplasia findings, especially atypical ones, are usually read alongside your family history. Suppose close relatives have had breast or endometrial cancer. Then an atypical hyperplasia finding may carry more weight. Your doctor may recommend closer monitoring. A referral to genetic counseling may also be offered. If you have no relevant family history, the same finding might lead to a more standard plan. This is one reason it helps to keep your family cancer history current. Make sure your care team has it on file before this conversation happens.

If you're being watched rather than treated right away, monitoring usually means a specific, written schedule, not just "come back if something changes." For breast atypical hyperplasia, this often means a clinical breast exam and imaging every six to twelve months for several years. For endometrial hyperplasia managed with progestin therapy, it typically means a repeat biopsy at three to six months to confirm the treatment is working, then ongoing checks after that. Ask your team to write down the specific schedule, rather than leaving it as a general plan, so you know exactly what to expect and when.

• American Cancer Society — Breast Hyperplasia (Ductal or Lobular)
• American Cancer Society — Understanding Your Pathology Report: Atypical Hyperplasia (Breast)
• ACOG — Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia (2023)